Cannabis

CHFA Position

Access to recreational cannabis should not be more liberal than access to cannabidiol (CBD) containing cannabis products that can improve the health of Canadians. 

We believe that by not reconciling the existing medical access with health products in parallel with the introduction of recreational cannabis, that the government has introduced unintended risks to those Canadians seeking benefits from cannabis products.  

Canadians want the same direct access to CBD health products as they have for recreational products.  By making CBD a prescription drug and preventing it from being used in Natural Health Products (NHPs), the Canadian government is driving Canadians to buy American products, seek products from dispensaries or other illegitimate retail outlets, or to experiment with recreational cannabis that lacks health product labelling and unnecessarily exposes them to THC.

Not all Canadians want to get high. 

Our industry and Canadian consumers should not have to wait for legitimate CBD-based NHPs to become available in Canada.